Several of these downstream effectors have activities that promote cancer development, such as stimulating cell proliferation and inhibiting apoptosis [16,42,71,107,108], and thus a subset of these targets may confer the tumorigenic effects of PAX3-FOXO1. This evidence concerns the gene PAX3 and cancer.